James A. Wilkins
Keine laufenden Positionen mehr
Profil
James A.
Wilkins held former positions as Director-Transfer & Technology Assessment at Genentech, Inc., Vice President-Process Development & Manufacturing at Alexion Pharmaceuticals, Inc., Chief Technology Officer at Sensor Innovations, Inc., Faculty Member at The Johns Hopkins University, and Professor at Yale University.
He received an undergraduate degree from The University of Texas at Austin and a doctorate from the University of Tennessee.
Ehemalige bekannte Positionen von James A. Wilkins
| Unternehmen | Position | Ende |
|---|---|---|
| The Johns Hopkins University | Corporate Officer/Principal | - |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
| Yale University | Corporate Officer/Principal | - |
Sensor Innovations, Inc.
 Sensor Innovations, Inc. BiotechnologyHealth Technology Sensor Innovations, Inc. develops and commercializes a novel, proprietary and versatile sensing technology platform. It is initially focusing on pH measurement in high-value manufacturing, where an internally referenced, continuously self-calibrating sensor without drift is advantageous. The company was founded by Carolyn R. Kahn in 2007 and is headquartered in Burlingame, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von James A. Wilkins
| The University of Texas at Austin | Undergraduate Degree |
| University of Tennessee | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Sensor Innovations, Inc.
Sensor Innovations, Inc. BiotechnologyHealth Technology Sensor Innovations, Inc. develops and commercializes a novel, proprietary and versatile sensing technology platform. It is initially focusing on pH measurement in high-value manufacturing, where an internally referenced, continuously self-calibrating sensor without drift is advantageous. The company was founded by Carolyn R. Kahn in 2007 and is headquartered in Burlingame, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
